Sonendo Balance Sheet Health

Financial Health criteria checks 3/6

Sonendo has a total shareholder equity of $28.4M and total debt of $37.4M, which brings its debt-to-equity ratio to 131.5%. Its total assets and total liabilities are $78.2M and $49.7M respectively.

Key information

131.5%

Debt to equity ratio

US$37.37m

Debt

Interest coverage ration/a
CashUS$46.78m
EquityUS$28.42m
Total liabilitiesUS$49.74m
Total assetsUS$78.16m

Recent financial health updates

Recent updates

Analysts Have Just Cut Their Sonendo, Inc. (NYSE:SONX) Revenue Estimates By 18%

Nov 10
Analysts Have Just Cut Their Sonendo, Inc. (NYSE:SONX) Revenue Estimates By 18%

A Piece Of The Puzzle Missing From Sonendo, Inc.'s (NYSE:SONX) Share Price

Apr 19
A Piece Of The Puzzle Missing From Sonendo, Inc.'s (NYSE:SONX) Share Price

Sonendo unit PIPStek files patent infringement lawsuit against Biolase

Jan 04

GAAP EPS of -$0.47 misses by $0.08, revenue of $9.8M beats by $0.49M

Nov 09

Sonendo announces $63 million private placement

Sep 23

Sonendo: Painful Debut For This Dental Play

Nov 07

Financial Position Analysis

Short Term Liabilities: SONX's short term assets ($65.3M) exceed its short term liabilities ($35.3M).

Long Term Liabilities: SONX's short term assets ($65.3M) exceed its long term liabilities ($14.4M).


Debt to Equity History and Analysis

Debt Level: SONX has more cash than its total debt.

Reducing Debt: Insufficient data to determine if SONX's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SONX has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: SONX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 6.8% each year


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.